Number of items: 1.
Grössmann, N. : Fedratinib (Inrebic®) for the treatment of primary and secondary myelofibrosis. Oncology Fact Sheet Nr. 33.
Grössmann, N. : Fedratinib (Inrebic®) for the treatment of primary and secondary myelofibrosis. Oncology Fact Sheet Nr. 33.